What is the future outlook for oral GLP-1 medications
Every step, no matter how small, is a step toward healing, strength, and freedom
Antibody-based design MariTide is an antibodypeptide conjugate, often described as a type of monoclonal antibody therapy
Why Some People Regain Weight After Stopping GLP-1 Therapy To understand how to keep the weight off, we must first understand why it comes back so fiercely for so many
The basal GLP-1 secretion in the low-glucose (0.1 mM) state was significantly inhibited by ESI-09, or ESI-09 with H-89, and was stimulated only by 007-AM, a selective EPAC activator (Fig
Compared with naltrexone-bupropion, semaglutide was associated with lower hazards of anxiety disorders, depression, cognitive deficits, and insomnia in adults with type 2 diabetes